Decreased expression of transforming growth factor β receptor type I is associated with poor prognosis in bladder transitional cell carcinoma patients

Clinical Cancer Research

Volumn 5, Issue 9, 1999, Pages 2520-2525

  Tokunaga, Hideo ^a   Lee, Dong Hyeon ^a   Kim, Isaac Yi ^a   Wheeler, Thomas M ^a   Lerner, Seth P ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; CYSTECTOMY; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION;

ACTIVIN RECEPTORS, TYPE I; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RISK FACTORS; SURVIVAL ANALYSIS; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 0032862085     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer statistics. CA Cancer J Clin., 47: 5-27, 1997.
2. Lerner, S. P., and Skinner, D. G. Radical cystectomy for bladder cancer. In: Nicholas J. Vogelzang, Peter T. Scardino, William U. Shipley, and Donald S. Coffey (eds.), Comprehensive Textbook of Genito-urinary Oncology, pp. 442-463. Baltimore: Williams and Wilkins, 1996.
3. Skinner, D. G., Daniels, J. R., Russell, C. A., Lieskovsky, G., Boyd, S. D., Nichols, P., Kern, W., Sakamoto, J., Krailo, M., and Groshen, S. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J. Urol., 145: 459-467, 1991.
4. Stockle, M., Meyenburg, W., Wellek, S., Voges, G., Gertenbach, U., Thurhoff, U. N., Huber, C., and Hohenfellner, R. Advanced bladder cancer (stages pT3b, pT4a, pN1, and pN2): improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy. Results of a controlled prospective study. J. Urol., 148: 302-307, 1992.
5. Franzen, P., ten Dijke, P., Ichijo, H., Yamashita, H., Schulz, P., Heldin, C-H., and Miyazono, K. Cloning of TGF-β type I receptor that forms a heteromeric complex with the TGF-β type II receptor. Cell, 75: 681-692, 1994.
6. Lin, H. Y., Wang, X., Ng-Eaton, E., Weinberg, R. A., and Lodish, H. F. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell, 68: 775-785, 1992.
7. Chen, F., and Weinberg, R. A. Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor-β receptor kinase. Proc. Natl. Acad. Sci. USA, 92: 1565-1569, 1995.
8. Wrana, J. L., Attisano, L., Wieser, R., Ventura, F., and Massagué, J. Mechanism of activation of the TGF-β receptor. Nature (Lond.), 370: 341-347, 1994.
9. Wilding, G. Response of prostate cells to peptide growth factors: transforming growth factor-β. Cancer Surv., 11: 147-163, 1991.
10. Hubbs, A. F., Hahn, F. F., and Thomassen, D. G. Increased resistance to transforming growth factor β accompanies neoplastic progression or rat tracheal epithelial cells. Carcinogenesis (Lond.), 10: 1599-1605, 1989.
11. Kawamata, H., Azuma, M., Kameyama, S., Nan, L., and Oyasu, R. Effect of epidermal growth factor/transforming growth factor β1 on growth in vitro of rat urinary bladder carcinoma cells. Cell Growth Differ., 3: 819-825, 1992.
12. Kerbel, R. S. Transition states in multicytokine responsiveness during tumor progression: human malignant melanoma as a paradigm. Proc. Am. Cancer Res., 34: 568-569, 1993.
13. Kim, I. Y., Ahn, H. J., Zelner, D. J., Shaw, J. W., Sensibar, J. A., Kim, J. H., Kato, M., and Lee, C. Genetic changes in transforming growth factor-β (TGF-β) receptor type I gene correlates with insensitivity to TGF-β1 in human prostate cancer cells. Cancer Res., 56: 44-48, 1996.
14. Park, K., Kim, S. J., Bang, Y. J., Park, J. G., Kim, N. K., Roberts, A. B., and Sporn, M. B. Genetic changes in transforming growth factor-β (TGF-β) type II receptor gene in human gastric cancer cell: correlation with sensitivity to growth inhibition by TGF-β. Proc. Natl. Acad. Sci. USA, 91: 8772-8776, 1994.
15. Markowitz, S., Wang, J., Meyeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., Brattain, M., and Willson, J. K. V. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science (Washington DC), 268: 1336-1338, 1995.
16. Wang, J., Sung, L. Z., Meyeroff, L., Wang, X, Gentry, L. E., Yang, J., Liang, J., Zborowska, E., Markowitz, S., Willson, J. K. V., and Brattain, M. G. Demonstration that mutation of type II TGF-β receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J. Biol. Chem., 220: 22044-22049, 1995.
17. Garrigue-Antar, L., Munor-Antonia, T., Antonia, S. J., Gesmonde, J., Vellucco, V. F., and Reiss, M. Missense mutations of transforming growth factor-β type II receptor in human head and neck squamous cell carcinoma cells. Cancer Res., 55: 3982-3987, 1995.
18. Eder, I. E., Stenzl, A., Hobisch, A., Cronauer, M. V., Bartsch, G., and Klocker, H. Transforming growth factors-β1 and β2 in serum and urine from patients with bladder carcinoma. J. Urol., 156: 953-957, 1996.
19. Okamoto, M., and Oyasu, R. Overexpression of transforming growth factor β type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line. Cell Growth Differ., 8: 921-926, 1997.
20. American Joint Committee on Cancer. AJCC Cancer Staging Manual, Ed. 5, pp. 241-243. Philadelphia: Lippincott-Raven, 1997.
21. Jessup, E. Antigen retrieval techniques for the demonstration of immunoglobulin light chains in formalin-fixed paraffin embedded sections. UK NEQAS Newsletter, 4: 12, 1994.
22. Lippa, C. F., Flanders, K. C., Kim, E. S., and Croul, S. TGF-β receptors-I and -II immunoexpression in Alzheimer's disease: a comparison with aging and progressive supranuclear palsy. Neurobiol. Aging, 19: 527-533, 1998.
23. Kim, W. S., Park, C., Jung, Y-S., Kim, H-S., Han, J., Park, C. H., Kim, K., Kim, J., Shim, Y. M., and Park, K. Reduced transforming growth factor-β type II receptor (TGF-β RII) expression in adenocarcinoma of the lung. Anticancer Res., 19: 301-306, 1999.
24. Yang, E. Y., and Moses, H. L. Transforming growth factor β1-induced changes on cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J. Cell Biol., 111: 731-741, 1990.
25. Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roche, N. S., Wakefield, L. M., Heine, U. I., Liotta, L. A., Falangam, V., Kehrl, J. H., and Fauci, A. S. Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. USA, 83: 4167-4171, 1986.
26. Johnson, D. W., Qumsiyeh, M., Benkhalifa, M., and Marchuk, D. A. Assignment of human transforming growth factor-β type I and type III receptor genes (TGFBRI and TGFBRIII) to 9q 33-34 and 1p32-33, respectively, Genomics, 28: 356-357, 1995.
27. Miyao, N., Tsai, Y. C., Lerner, S. P., Olumni, A. F., Spruck, C. H., III, Gonzales-Zuleta, M., Nichols, P. W., Skinner, D. G., and Jones, P. A. Role of chromosome 9 in human bladder cancer. Cancer Res., 53: 4066-4070, 1993.